(E)-1-(6-acetyl-9-octylcarbazol-3-yl)-3-(4-methoxyphenyl)prop-2-en-1-one
C32H35NO3 — CID 162643118
Data last refreshed: (MolForge compound catalog, from PubChem)
About (E)-1-(6-acetyl-9-octylcarbazol-3-yl)-3-(4-methoxyphenyl)prop-2-en-1-one
(E)-1-(6-acetyl-9-octylcarbazol-3-yl)-3-(4-methoxyphenyl)prop-2-en-1-one (PubChem CID 162643118) has the molecular formula C32H35NO3 and a molecular weight of 481.64 g/mol. Its IUPAC name is (E)-1-(6-acetyl-9-octylcarbazol-3-yl)-3-(4-methoxyphenyl)prop-2-en-1-one.
Molecular Properties
| Compound Name | (E)-1-(6-acetyl-9-octylcarbazol-3-yl)-3-(4-methoxyphenyl)prop-2-en-1-one |
|---|---|
| PubChem CID | 162643118 |
| Molecular Formula | C32H35NO3 |
| Molecular Weight | 481.64 g/mol |
| Exact Mass | 481.26 |
| IUPAC Name | (E)-1-(6-acetyl-9-octylcarbazol-3-yl)-3-(4-methoxyphenyl)prop-2-en-1-one |
| SMILES | CCCCCCCCn1c2ccc(C(C)=O)cc2c2cc(C(=O)/C=C/c3ccc(OC)cc3)ccc21 |
| InChI | InChI=1S/C32H35NO3/c1-4-5-6-7-8-9-20-33-30-17-13-25(23(2)34)21-28(30)29-22-26(14-18-31(29)33)32(35)19-12-24-10-15-27(36-3)16-11-24/h10-19,21-22H,4-9,20H2,1-3H3/b19-12+ |
| InChIKey | FBMUCAGIWZIZIC-XDHOZWIPSA-N |
| XLogP | 8.26 |
| TPSA | 48.30 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 481.64 |
| LogP ≤ 5 | 8.26 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162643118 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.